Aptevo Therapeutics Inc. Operating Lease Right-of-Use Assets
Aptevo Therapeutics Inc. (APVO) had Operating Lease Right-of-Use Assets of $3.48 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-14
- 2026-06-30: Operating Lease, Right-of-Use Asset $3.48M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $3.65M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $3.81M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $3.96M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $3.48M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $3.65M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $3.81M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $3.96M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $4.11M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $4.25M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $4.39M 10-K · filed 2026-03-26 |
| 2024-09-30 | $4.52M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $4.64M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $4.77M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $4.88M 10-K · filed 2025-02-14 |
| 2023-09-30 | $4.99M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $5.10M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $5.20M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $5.30M 10-K · filed 2024-03-05 |
| 2022-09-30 | $5.41M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $5.51M 10-Q · filed 2022-08-11 |
| 2022-05-26 | $4.40M 10-K · filed 2024-03-05 |
| 2022-03-31 | $1.31M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.58M 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.86M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $2.16M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.44M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.72M 10-K · filed 2022-03-24 |
| 2020-09-30 | $2.99M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $3.25M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $3.50M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $3.75M 10-K · filed 2021-03-31 |
| 2019-09-30 | $3.98M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $4.26M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $4.48M 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |